Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,157 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07383441RecruitingPhase 3
Adding Biotherapy or Placebo to Standard Kidney Cancer Treatment
This trial tests whether adding a biotherapy (a special drug from a living source) or a placebo to standard treatments helps people with advanced kidney cancer. It may be a good option if your cancer hasn't been treated yet and you are in fairly good health.
Fayetteville, ArkansasAges 18 years+ - NCT06837298Recruiting
Fava bean extract supplement for muscle recovery
This trial tests whether a supplement made from fava bean protein can help your muscles recover strength after exercise. You would take the supplement for about 2 weeks and have your muscle function tested before and after.
Bradenton, FloridaAges 18–45 - NCT07373808Recruiting
Nerve stimulation and exercise for sciatica leg pain
This study tests whether combining a mild electrical stimulation of the sciatic nerve with specific exercises can reduce leg pain from sciatica. It is for people whose nerve-related leg pain has lasted over 6 months and is at least a 3 out of 10 in intensity.
Madrid, MadridAges 18–70 - NCT07373210Recruiting
Placebo pills for hip surgery pain in teens and young adults
This study tests whether taking placebo pills (pills with no active drug) can help manage pain after a specific hip surgery, called Bernese Periacetabular Osteotomy (PAO), in people with a hip condition called developmental dysplasia. The goal is to see if using placebos can reduce the need for pain medications and help with recovery.
San Francisco, CaliforniaAges 13–40 - NCT07377357Recruiting
Electrical stimulation for chronic back-related leg pain
This trial tests if a single session of electrical stimulation to the sciatic nerve can quickly reduce leg pain related to low back problems. It may help if you have had chronic sciatica (leg pain from your back) for more than 6 months and your pain has recently been interfering with daily life.
Madrid, MadridAges 18–70 - NCT07377175RecruitingPhase 1
Safety study of BSY001 in healthy adults
This early-phase trial tests a single or multiple doses of BSY001 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 50 who are not allergic to similar drugs and can avoid certain medicines and activities during the study.
HangzhouAges 18–50 - NCT07377721RecruitingPhase 1
Study of HRS-2129 for diabetic nerve pain
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07378098RecruitingPhase 3
Study of KLH-2109 for uterine fibroids with heavy bleeding
This trial tests a new medicine called KLH-2109 for women who have uterine fibroids that cause heavy menstrual bleeding. The goal is to see if the medicine can reduce bleeding and improve symptoms.
SeoulAges 19 years+ - NCT07367672Recruiting
How beliefs affect pain empathy
This trial studies how our expectations can change how we feel pain for others. It may help us understand the placebo effect better.
Chengdu, SichuanAges 18–30 - NCT07364565Recruiting
Green tea mouthwash for plaque and gum health
This trial tests whether a pure green tea mouthwash can reduce plaque and gum inflammation better than a placebo or an essential oils mouthwash. It may be a good option if you have healthy gums and are looking for a natural alternative.
Irbid, Irbid GovernorateAges 18 years+ - NCT07365462RecruitingPhase 2
Study of NBI-1065890 for tardive dyskinesia in adults
This trial tests whether an oral medication, NBI-1065890, can reduce the involuntary muscle movements caused by long-term use of antipsychotic drugs. It is for adults with moderate to severe tardive dyskinesia who also have a stable mental health condition like schizophrenia or bipolar disorder.
Bryant, ArkansasAges 18–75 - NCT04974138RecruitingPhase 4
Preventing first stroke in people with high-risk blood pressure
This trial tests whether a study medicine regimen can help prevent a first stroke in people with hard-to-control “high homocysteine” risk factors linked to a specific gene type. You may qualify if you have certain blood pressure levels, a specific MTHFR gene result, and related blood test findings.
Bengbu, AnhuiAges 45–74 - NCT07357051RecruitingPhase 3
Flu treatment study for children ages 2 to 12
This trial tests a new oral medicine (JKN2301) for children with the flu. It aims to see if the medicine is safe and works well to treat flu symptoms like fever and cough.
Guangzhou, GuangdongAges 2–11 - NCT07359625Recruiting
Study on ketone drinks and insulin health
This study tests if drinking a ketone supplement can improve how your body responds to insulin, which affects blood sugar control.
Aarhus NAges 55–70 - NCT06850454RecruitingPhase 3
Olanzapine vs placebo for nausea from first chemo
This study tests if the drug olanzapine (commonly used for nausea) can help prevent vomiting in people receiving moderately strong chemotherapy for the first time. It may be a good fit if you're about to start treatment with oxaliplatin, irinotecan, or carboplatin and haven't had severe nausea treatments before.
Bangkok, BangkokAges 18 years+ - NCT07351734RecruitingPhase 2
Testing JKN2403 for COPD: a new treatment option
This study tests an experimental drug called JKN2403 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve breathing compared to a placebo (a dummy pill).
Guangzhou, GuangdongAges 40–80 - NCT07345364RecruitingPhase 1
Safety of single dose SIM0811 in healthy adults
This trial tests a single dose of an investigational drug called SIM0811 in healthy Chinese adults. The goal is to see if it's safe and how the body processes it, so researchers can find the right dose for future studies.
Jinan, ShandongAges 18–45 - NCT07346989Recruiting
Brain stimulation to improve function in frail older adults
This study uses a gentle, non-invasive brain stimulation technique (called transcranial direct current stimulation, or tDCS) to see if it can improve physical function and daily activities in older adults who are showing early signs of frailty. You will be asked to do some simple exercises and cognitive tasks while receiving or not receiving the stimulation.
Valencia, ValenciaAges 65–90 - NCT06263959RecruitingPhase 2
Testing a new hepatitis B pill (GST-HG131) for chronic HBV
This study tests a new drug, GST-HG131, for people with chronic hepatitis B who are already on stable treatment. It aims to see if the drug is safe and reduces the virus further.
BeijingAges 35–65 - NCT07327034RecruitingPhase 2
ABSK-011 with standard care for advanced liver cancer
This trial tests a new drug, ABSK-011, combined with standard care, against a placebo with standard care for people with advanced liver cancer that has a specific marker called FGF19 overexpression. The goal is to see if ABSK-011 can help slow the disease.
Hefei, AnhuiAges 18 years+ - NCT07330154Recruiting
Gel for Faster Healing After Gum Graft Surgery
This trial tests a new gel (Nano Bio Fusion Gingival Gel) to see if it helps the roof of your mouth heal faster after a gum graft. It compares the gel to a placebo (inactive gel). The study is for people who need gum graft surgery for receding gums.
Irbid, Irbid GovernorateAges 18 years+ - NCT07317544RecruitingPhase 1/Phase 2
ABS-201 trial for hair loss in healthy adults
This trial tests a new medicine (ABS-201) in healthy people to see if it is safe and works for hair loss. It involves multiple doses and compares results based on whether you have the common type of hair loss called androgenetic alopecia.
Sydney, New South WalesAges 18–65 - NCT06371157RecruitingPhase 3
Testing AK104 and Lenvatinib with TACE for liver cancer
This trial tests if adding a new combination of drugs (AK104 and lenvatinib) to a standard liver cancer procedure called TACE is more effective than TACE alone. It is for people whose liver cancer has not spread and cannot be removed by surgery, but who are well enough to receive these treatments.
Zhengzhou, HenanAges 18–75 - NCT04996017RecruitingPhase 3
Atezolizumab after surgery for malignant pleural mesothelioma
This study tests whether atezolizumab given after surgery and chemotherapy can lower the risk of mesothelioma coming back compared with a placebo. It may help by boosting the immune system to control remaining microscopic cancer cells.
Meldola, ITAòYAges 18 years+
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,157 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.